香港股市 已收市

Intuitive Surgical, Inc. (ISRG)

NasdaqGS - NasdaqGS 即時價格。貨幣為 USD。
加入追蹤清單
375.33+2.21 (+0.59%)
收市:04:00PM EDT
372.21 -3.12 (-0.83%)
收市後: 07:46PM EDT

Intuitive Surgical, Inc.

1020 Kifer Road
Sunnyvale, CA 94086-5304
United States
408 523 2100
https://www.intuitive.com

版塊Healthcare
行業Medical Instruments & Supplies
全職員工13,676

高階主管

名稱頭銜支付行使價出生年份
Dr. Gary S. Guthart Ph.D.CEO & Director2.62M26.28M1966
Mr. David J. RosaPresident1.63M37.79M1968
Mr. Jamie E. SamathSenior VP & CFO1.01M1971
Mr. Henry L. CharltonSenior VP & Chief Commercial and Marketing Officer1.08M1970
Mr. Robert DeSantisExecutive VP and Chief Strategy & Corporate Operations Officer1.26M1.01M1966
Mr. Fredrik WidmanVP, Principal Accounting Officer & Corporate Controller
Mr. Gary H. Loeb J.D.Senior VP, General Counsel & Chief Compliance Officer1970
Dr. Christopher R. Carlson Ph.D.Executive Vice President of Research, Corporate Development & Intuitive Ventures
Mr. Marshall L. MohrExecutive Vice President of Global Business Services1.2M1956
Dr. Myriam J. Curet McAdams F.A.C.S., M.D.Executive VP & Chief Medical Officer1.19M5.25M1957
截止 2023年12月31日為止計算的金額,現金賠償則計算至上一個財政年度末止。薪資是指薪俸、獎金等。已行使價是指財政年度期間已行使的期權價值。貨幣為 USD。

描述

Intuitive Surgical, Inc. develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System that enables complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung. It also provides a suite of stapling, energy, and core instrumentation for its multi-port da Vinci surgical systems; progressive learning pathways to support the use of its technology; infrastructure of service and support specialists, a complement of services to its customers, including installation, repair, maintenance, 24/7 technical support, and proactive system health monitoring; and integrated digital capabilities providing connected offerings, streamlining performance for hospitals with program-enhancing insights. The company sells its products through direct sales organizations, such as capital and clinical sales teams. It has a collaboration agreement with FluoGuide A/S for head & neck cancer. The company was incorporated in 1995 and is headquartered in Sunnyvale, California.

公司管治

截至 2024年4月1日 止,Intuitive Surgical, Inc. 的 ISS 管治質素評分為 3。 Pillar 分數正在審核中:4;董事會:3;股東權利:4;現金賠償:7。

企業管治評分的資料提供: Institutional Shareholder Services (ISS). 評分將以 1 至 10 分顯示 (與指數或地區相關)。1 分表示較低的管治風險,而 10 分表示較高的管治風險。